Koers Chengdu Kanghong Pharmaceutical Group Co., Ltd
Aandelen
002773
CNE1000020C4
Farmaceutische producten
slotkoers
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
22,1 CNY | -1,12% | -2,26% | +19,85% |
Omzet 2024 * | 4,3 mld. 594 mln. 545 mln. | Omzet 2025 * | 4,95 mld. 683 mln. 627 mln. | Marktkapitalisatie | 20,32 mld. 2,81 mld. 2,58 mld. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | 1,22 mld. 168 mln. 154 mln. | Nettowinst (verlies) 2025 * | 1,46 mld. 202 mln. 185 mln. | EV/omzet 2024 * | 4,72 x |
Nettoliquiditeiten 2024 * | - 0 0 | Nettoliquiditeiten 2025 * | - 0 0 | EV/omzet 2025 * | 4,11 x |
K/w-verhouding 2024 * |
16,7
x | K/w-verhouding 2025 * |
13,9
x | Werknemers | 4.289 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 28,62% |
1 dag | -1,12% | ||
1 week | -2,26% | ||
Lopende maand | -1,12% | ||
1 maand | +1,84% | ||
3 maanden | +27,38% | ||
6 maanden | +17,62% | ||
Lopend jaar | +19,85% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Jian Jun Zhong
DFI | Director of Finance/CFO | 57 | - |
Xiao Ke
PSD | President | 41 | 01-01-12 |
Jin Qun Yin
BRD | Director/Board Member | 52 | 21-06-13 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jian Rong Zhong
BRD | Director/Board Member | 67 | 01-01-12 |
Zun Hong Ke
CHM | Chairman | 70 | 01-01-98 |
Xiao Ke
PSD | President | 41 | 01-01-12 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
0.00% | 34 M€ | +4,01% | - |
Datum | Koers | Variatie | Volume |
---|---|---|---|
03-06-24 | 22,1 | -1,12% | 7 767 230 |
31-05-24 | 22,35 | +0,13% | 6 989 883 |
30-05-24 | 22,32 | +0,13% | 7 245 228 |
29-05-24 | 22,29 | -0,13% | 5 932 328 |
28-05-24 | 22,32 | -2,45% | 5 668 110 |
slotkoers Shenzhen S.E., 03 juni 2024
Meer koersenHerzieningen van WPA
Winst van het jaar - Afwijkingspercentage
Vaira. 1 jan. | Kapi. | |
---|---|---|
+19,85% | 2,84 mld. | |
+43,04% | 739 mld. | |
+32,34% | 598 mld. | |
-6,14% | 353 mld. | |
+17,31% | 318 mld. | |
+3,27% | 285 mld. | |
+16,47% | 240 mld. | |
+9,26% | 210 mld. | |
-5,07% | 206 mld. | |
+5,84% | 164 mld. |